Growth Hormone Deficiency (GHD)
Endocrinology·MeSH: Dwarfism, Pituitary
Prevalence
30.0 / 100K
5 drugs in development·4 companies·4 clinical trials
Drug Pipeline by Phase
Compare drugs
Frequently asked questions
How many drugs are in development for Growth Hormone Deficiency (GHD)?
BioSniper tracks 5 drugs in development for Growth Hormone Deficiency (GHD) across 4 companies.
How many clinical trials target Growth Hormone Deficiency (GHD)?
There are 4 clinical trials targeting Growth Hormone Deficiency (GHD) tracked by BioSniper.
What is the prevalence of Growth Hormone Deficiency (GHD)?
The estimated prevalence of Growth Hormone Deficiency (GHD) is approximately 30.0 per 100,000 population.
Deep-dive into Growth Hormone Deficiency (GHD)
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis